טוען...
Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study
BACKGROUND: In hemodialysis patients, post-dialysis treatment with intravenous antibiotics permits even severe infections to be managed on an outpatient basis. Cefepime is a fourth-generation cephalosporin with a broad spectrum of action in monotherapy. We report on the pharmacokinetics of cefepime...
שמור ב:
| הוצא לאור ב: | BMC Pharmacol Toxicol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4743204/ https://ncbi.nlm.nih.gov/pubmed/26846675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-016-0048-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|